Skip to Content

Pazopanib

In the US, Pazopanib (pazopanib systemic) is a member of the drug class VEGF/VEGFR inhibitors and is used to treat Renal Cell Carcinoma and Soft Tissue Sarcoma.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XE11

CAS registry number (Chemical Abstracts Service)

0444731-52-6

Chemical Formula

C21-H23-N7-O2-S

Molecular Weight

437

Therapeutic Category

Cytostatic agent

Chemical Name

5-({4-[(2,3-dimetyl-2H-indazol-6-yl)metylamino]pyrimidin-2-yl}amino)-2-metylbenzenesulfonamide (WHO)

Foreign Names

  • Pazopanibum (Latin)
  • Pazopanib (German)
  • Pazopanib (French)
  • Pazopanib (Spanish)

Generic Names

  • Pazopanib (OS: BAN)
  • GW 786034 (IS)
  • UNII-7RN5DR86CK (IS)
  • Pazopanib Hydrochloride (OS: USAN, BANM, JAN)
  • GW786034B (IS)
  • UNII-33Y9ANM545 (IS)

Brand Names

  • Votrient
    Glaxo Group, Lithuania; Glaxo Wellcome, Portugal; Glaxo Wellcome, Serbia; GlaxoSmithKline, Chile; GlaxoSmithKline, Colombia; GlaxoSmithKline, France; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Singapore; GSK, Turkey; Wellcome Limited, Bosnia & Herzegowina; Glaxo Group, Austria; Glaxo Group, Hungary; Glaxo Group, Iceland; Glaxo Group, Romania; GlaxoSmithKline, Argentina; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Costa Rica; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Guatemala; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Honduras; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Latvia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Philippines; GlaxoSmithKline, Sweden; GlaxoSmithKline, El Salvador; GlaxoSmithKline, Vietnam

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

(web1)